Abstract
There is a lack of evidence about whether menopausal status influences the effect of smoking on lung function. This study examined the association between smoking and menopausal status and lung function independent of each other. Data were from a cohort of women attending the 21-year follow-up of the Mater University of Queensland Study of Pregnancy. The study was based on 2020 women who provided data on respiratory function, smoking, and menopausal status. A Spirobank G spirometer system was used to measure forced vital capacity (FVC), forced expiratory volume in first second (FEV1), and forced expiratory flow between 25 and 75% of forced vital capacity (FEF25–75). Smoking and menopausal status were assessed by self-report. Respiratory function was associated with cigarette smoking, menopausal status, and hormone replacement therapy. Regardless of smoking status, postmenopausal women had poorer lung function when compared with premenopausal women. In multivariate analysis, cigarette smoking was associated with lower FVC, FEV1, and FEF25–75, with the magnitude of effect being stronger for women who were postmenopausal. The data suggest that the impact of smoking intensifies after menopause. It seems plausible that effective quit-smoking programs, particularly after menopause, may lead to better lung function and reduced morbidity and mortality in women.
Similar content being viewed by others
References
Balzano G, Fuschillo S, Melillo G, Bonini S (2001) Asthma and sex hormones. Allergy 56:13–20
Troisi RJ, Speizer FE, Willett WC, Trichopoulos D, Rosner B (1995) Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma: a prospective cohort study. Am J Respir Crit Care Med 152:1183–1188
Gómez Real F, Svanes C, Björnsson EH, Franklin KA, Gislason D, Gislason T, Gulsvik A, Janson C, Jögi R, Kiserud T, Norbäck D, Nyström L, Torén K, Wentzel-Larsen T, Omenaas E (2006) Hormone replacement therapy, body mass index and asthma in perimenopausal women: a cross sectional survey. Thorax 61:34–40
Real FG, Svanes C, Omenaas ER, Antò JM, Plana E, Jarvis D, Janson C, Neukirch F, Zemp E, Dratva J, Wjst M, Svanes K, Leynaert B, Sunyer J (2008) Lung function, respiratory symptoms, and the menopausal transition. J Allergy Clin Immunol 121:72–80.e73
Real FG, Svanes C, Omenaas ER, Anto JM, Plana E, Janson C, Jarvis D, Zemp E, Wjst M, Leynaert B, Sunyer J (2007) Menstrual irregularity and asthma and lung function. J Allergy Clin Immunol 120:557–564
Salam MT, Wenten M, Gilliland FD (2006) Endogenous and exogenous sex steroid hormones and asthma and wheeze in young women. J Allergy Clin Immunol 117:1001–1007
Svanes C, Real FG, Gislason T, Jansson C, Jögi R, Norrman E, Torén K, Omenaas E (2005) Association of asthma and hay fever with irregular menstruation. Thorax 60:445–450
Ojoo JC, Kastelik JA, Mori AH (2001) The respiratory system and the menopause. Menopause Int 7:168–173
Gan WQ, Man SF, Postma DS, Camp P, Sin DD (2006) Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res 7:52
Pata Ö, Atis S, Utku Öz A, Yazici G, Tok E, Pata C, Kiliç F, Camdeviren H, Aban M (2003) The effects of hormone replacement therapy type on pulmonary functions in postmenopausal women. Maturitas 46:213–218
Mueller JE, Frye C, Brasche S, Heinrich J (2003) Association of hormone replacement therapy with bronchial hyper-responsiveness. Respir Med 97:990–992
Carlson CL, Cushman M, Enright PL, Cauley JA, Newman AB (2001) Hormone replacement therapy is associated with higher FEV1 in elderly women. Am J Respir Crit Care Med 163:423–428
Juniper EF, Daniel EE, Roberts RS, Kline PA, Hargreave FE, Newhouse MT (1989) Improvement in airway responsiveness and asthma severity during pregnancy. A prospective study. Am Rev Respir Dis 140:924–931
Stenius-Aarniala B, Piirila P, Teramo K (1988) Asthma and pregnancy: a prospective study of 198 pregnancies. Thorax 43:12–18
Schatz M, Harden K, Forsythe A, Chilingar L, Hoffman C, Sperling W, Zeiger RS (1988) The course of asthma during pregnancy, post partum, and with successive pregnancies: a prospective analysis. J Allergy Clin Immunol 81:509–517
Strinic T, Eterovic D (2003) Oral contraceptives improve lung mechanics. Fertil Steril 79:1070–1073
Chandler MH, Schuldheisz S, Phillips BA, Muse KN (1997) Premenstrual asthma: the effect of estrogen on symptoms, pulmonary function, and beta 2-receptors. Pharmacotherapy 17:224–234
Downs SH, Brandli O, Zellweger JP, Schindler C, Kunzli N, Gerbase MW, Burdet L, Bettschart R, Zemp E, Frey M, Keller R, Tschopp JM, Leuenberger P, Ackermann-Liebrich U, SAPALDIA team (2005) Accelerated decline in lung function in smoking women with airway obstruction: SAPALDIA 2 cohort study. Respir Res 6:45
Willemse BWM, Postma DS, Timens W, ten Hacken NHT (2004) The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 23:464–476
Connett JE, Murray RP, Buist AS, Wise RA, Bailey WC, Lindgren PG, Owens GR, Lung Health Study Research Group (2003) Changes in smoking status affect women more than men: results of the Lung Health Study. Am J Epidemiol 157:973–979
Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS et al (1995) Optimal assessment and management of chronic obstructive pulmonary-disease (COPD). The European Respiratory Society Task Force. Eur Resp J 8:1398–1420
Baron JA, La Vecchia C, Levi F (1990) The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 162:502–514
Hayatbakhsh MR, Najman JM, Jamrozik K, Mamun AA, Alati R, Bor W (2007) Cannabis and anxiety and depression in young adults: a large prospective study. J Am Acad Child Adolesc Psychiatry 46:408–417
Najman JM, Bor W, O’Callaghan M, Williams GM, Aird R, Shuttlewood G (2005) Cohort profile: The Mater University of Queensland Study of Pregnancy (MUSP). Int J Epidemiol 34:992–997
American Thoracic Society (1995) Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 152:1107–1136
Bromberger JT, Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P (1997) Prospective study of the determinants of age at menopause. Am J Epidemiol 145:124–133
Dudley EC, Hopper JL, Taffe J, Guthrie JR, Burger HG, Dennerstein L (1998) Using longitudinal data to define the perimenopause by menstrual cycle characteristics. Climacteric 1:18–25
Jakesz R, Jonat W, Gnant M, Mittlboeck M, Greil R, Tausch C, Hilfrich J, Kwasny W, Menzel C, Samonigg H, Seifert M, Gademann G, Kaufmann M, Wolfgang J, ABCSG and the GABG (2005) Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years’ adjuvant tamoxifen: Combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366:455–462
Hole DJ, Watt GCM, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM (1996) Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 313:711–715
Knuiman MW, James AL, Divitini ML, Ryan G, Bartholomew HC, Musk AW (1999) Lung function, respiratory symptoms, and mortality: results from the busselton health study. Ann Epidemiol 9:297–306
Acknowledgments
We thank all participants in the study, the MUSP data collection team, and Greg Shuttlewood of the University of Queensland who has helped to manage the data for the MUSP. The study was funded by the National Health and Medical Research Council (NHMRC) of Australia, but the views expressed in the article are those of the authors and not necessarily those of any funding body.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hayatbakhsh, M.R., Najman, J.M., O’Callaghan, M.J. et al. Association Between Smoking and Respiratory Function Before and After Menopause. Lung 189, 65–71 (2011). https://doi.org/10.1007/s00408-010-9269-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-010-9269-9